Table Of Content

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR VOLUME 50, 1995 SUBJECT AND AUTHOR INDEX © PERGAMON PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR Founded by MATTHEW J. WAYNER US Editor-in-Chief European Editor-in-Chief GEORGE F. Koos SANDRA E. FILE Department of Neuropharmacology, CVN7 Psychopharmacology Research Unit The Scripps Research Institute Guy’s Hospital Medical School 10666 N. Torrey Pines Road P.O. Box 3448 La Jolla, CA 92037, USA London SE1 9QH, UK Fax: (619) 752-1595 Fax: 44-171-955-4627 E-mail: [email protected] E-mail: [email protected] Editorial Advisory Board LIISA AHTEE, Helsinki, Finland J. DAVID LEANDER, Indianapolis, IN LEMBIT ALLIKMETS, Tartu, Estonia EMINY H. Y. LEE, Taipei, Taiwan ROBERT L. BALSTER, Richmond, VA ALLEN S. LEVINE, Minneapolis, MN GIOVANNI BIGGIO, Cagliari, Italy WILLIAM J. McBRIDE, Indianapolis, IN MIKE BRILEY, Castres, France DONALD E. McMILLAN, Little Rock, AR ALLAN C. COLLINS, Boulder, CO JACK H. MENDELSON, Belmont, MA DONALD V. COSCINA, Toronto, Ontario, Canada FATHY S. MESSIHA, Grand Forks, ND JACQUELINE N. CRAWLEY, Bethesda, MD ROBERT D. MYERS, Greenville, NC ANNETTE DOMENEY, Geneva, Switzerland JUDITH A. PRATT, Glasgow, UK ADRIAN J. DUNN, Shreveport, LA JAQUELINE SAGEN, Chicago, IL BURR EICHELMAN, Philadelphia, PA ROSARIO SAMANIN, Milan, Italy WILLIAM J. FREED, Washington, DC HERMAN H. SAMSON, Winston-Salem, NC MANUEL FREIRE-GARABAL, Santiago De Compostela, Spain PAUL R. SANBERG, Tampa, FL RICHARD A. GLENNON, Richmond, VA PHIL J. SKOLNICK, Bethesda, MD F. G. GRAEFF, Sao Paulo, Brazil LINDA P. SPEAR, Binghamton, NY M. R. C. GREENWOOD, Davis, CA CLARE STANFORD, London, UK ROLAND R. GRIFFITHS, Baltimore, MD MARIE-HELENE THIEBOT, Paris, France STEPHEN G. HOLTZMAN, Atlanta, GA DEREK VAN DER KOOY, Toronto, Ontario, Canada AKIRA HORITA, Seattle, WA JEANNE M. WEHNER, Boulder, CO CHRIS E. JOHANSON, Baltimore, MD BRUNO E. WILL, Strasbourg, France HAROLD KALANT, Toronto, Ontario, Canada J.C. WINTER, Buffalo, NY G. JEAN KANT, Washington, DC ALICE M. YOUNG, Detroit, MI KATHLEEN M. KANTAK, Boston, MA IAN S. ZAGON, Hershey, PA CONAN KORNETSKY, Boston, MA PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR Managing Editors: In the US: In Europe: Gery Schulteis Nick Andrews E-mail: [email protected] E-mail: [email protected] Production Editor: Alayne A. Bakken E-mail: [email protected] Publishing, Subscription, and Advertising Offices: Elsevier Science Inc., 660 White Plains Road, Tarrytown, NY 10591-5153, USA, E-mail Address: [email protected]; and Elsevier Science Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, England Published Monthly Annual Institutional Subscription Rates (1995): North, Central and South America, US$1580.00, Rest of World £1060.00. Associated Personal Subscription Rates are available on request for those whose institutions are library subscribers. Sterling prices exclude VAT. Non-VAT registered customers in the European Community will be charged the appropriate VAT in addition to the price listed. Prices include postage and insurance and are subject to change without notice. Pharmacology Biochemistry and Behavior is an official journal of the International Behavioral Neuroscience Society. For information about the society, please contact: Marianne Van Wagner, IBNS Central Office, Division of Life Sciences, The University of Texas at San Antonio, 6900 North Loop 1604 West, San Antonio, TX 78249- 0662, USA. E-mail: [email protected]; Fax: (210) 691-4510. Members of the International Behavioral Neuroscience Society may order personal subscriptions at a concessional rate; details of this rate are available upon request. Pharmacology Biochemistry and Behavior, Vol. 50, No. 4, pp. I- VIII, 1995 Copyright © 1995 Elsevier Science Ltd Pergamon Printed in the USA. All rights reserved 0091-3057/95 $9.50 + .00 SUBJECT INDEX Abuse liability, 171 B-Adrenoceptor antagonists, 339 Cycloheximide, 499 Acoustic startle, 191 Beta-carboline, 551 Cyproheptadine, 383 Acquisition, 571 Bicuculline, 199, 253 Cytokines, 141 Acquisition memory, 321 Blocking of olfactory cues, 233 Active avoidance, 509 Blood pressure, 253, 389 D,, 359 Activity, 207 Body temperature, 389, 473 D, dopamine postsynaptic receptors, 613 Acute-phase response, 675 Brain, 321, 421, 457, 491 D, dopamine receptor agonists, 333 Adaptation, 545 Brain asymmetry, 359 D, receptor, 153 ADP-ribosylation, 327 Brain histamine content, 321 D, receptor binding, 333 Adrenal gland, 551 Brain regions, 635 D, dopamine autoreceptors, 29 Adrenalectomy, 405 Buprenorphine, 271 D, dopamine postsynaptic receptors, 613 Adult behavioral responses, 277 Buspirone, 477 D, dopamine receptors, 29 Age, 191 Buthionine sulfoximine, 491 D, dopamine receptor agonists, 333 Aggression, 671 D, receptor, 153 Aggressive behavior, 481 C57BL/6J, 163 D, receptor binding, 333 Aging, 65, 207, 661 Ca-antagonist, 509 d-Amphetamine, 551 Alcohol, 265, 563, 619 Caffeine pharmacokinetics, 245 DA transporter, 593 Alcohol consumption, 265 Calcium, 293 DBA/2J, 163 Alcohol drinking, 265 Calcium channel blocker, 293 De-nicotinized cigarette, 91 Alcohol-preferring rats, 265 Carassius auratus, 77 Dehydroevodiamine, 293 Alfentanil, 351 Catalepsy, 141, 259, 431 Delayed matching to sample, 641 a-Melanocyte-stimulating hormone, 339 CCK, agonists, 133 Dentate gyrus, 327 Ambient temperature, 473 CCK, agonists, 133 Depression, 147 Amnesia, 499 Central nervous system, 219 Desipramine, 481 Amphetamine, 41, 345, 601 Central peptide receptors, 463 Development, 491 Analgesia, 17 Central stimulants, 601 Diazepam, 665 Angiotensin II, 457 CFT, 627 Differentiation, 641 Anogenital distance, 413 CGP37849, 9 Dimethylxanthines, 245 Anorexia, 287, 369 CGP39551,9 Diurnal cycle, 421 Anorexigenic drug, 485 Chicken, 55 Dizocilpine, 305 Anticancer response, 399 Chlordiazepoxide, 107, 345 DL-fenfluramine, 581 Anticonflict, 477 Choice, 571 DMSO, 521, 527 Antiestrogen, 55 Chromium, 607 DNQX, 305 Antinociception, 421, 587 Chronic treatment, 259, 477 DOI, 309, 545 Anxiety, 277, 375 Circadian rhythm, 207 Dominance, 671 Anxiolytics, 253 Classical conditioning, 299 Dominant, 655 a,-Adrenoceptors, 287 Clentiazem, 509 Dopamine, 41, 77, 83, 127, 153, 359, 437, Apomorphine, 1, 83 Clonidine, 219 563, 649 Ascorbic acid oxidation, 1 CNS depression, 199 Dopamine agonists, 147, 389 Ataxia, 49 Cocaine, 23, 163, 601, 613, 627 Dopamine antagonists, 147 Atenolol, 225 Cocaine abuse, 71 Dopamine metabolism, 83, 333 a,-Adrenoceptors, 219 Color and position discrimination, 641 Dopamine receptors, 35 Autoreceptors, 83 Conditioned position responding, 641 Dopamine receptor supersensitivity, 23 Aversive conditioning, 661 Conditioned preference, 121 Dose-response, 539 Conditioned taste aversion, 299, 675 Down-regulation of B-adrenoceptor, 225 Barbiturates, 9 Conditioned taste avoidance, 299 Drug abuse, 171 Behavior, 1, 115, 453, 473, 539 Conditioning CTL activity, 399 Drug discrimination, 107, 211, 601 Behavior genetics, 163 Conscious rats, 219 Drug reinforcement, 299, 571 Behavioral, 607 Convulsion, 49 Drug self-administration, 71, 171, 571, 619 Behavioral activation, 437 Corticosterone, 405 DSP-4, 481 Behavioral analysis, 463 Corticostriatal glutamatergic pathways, | DTG, 587 Behavioral sensitization, 613 Crab, 445 Dyskinesia, 181 Behavioral toxicology, 97 Critical periods, 97 Benzodiazepines, 171, 253, 345 Crosstolerance, 9 Ear-scratch response, 545 B-Adrenoceptors, 241 CY 208-243, 153 ECS, 499 IV SUBJECT INDEX EEDQ, 127 Hedonics, 121 Memory impairment, 509 Egg laying, 55 Hereditary catalepsy, 383 Met-enkephalin, 445 8-OH-DPAT, 375 Hippocampus, 551 Methcathinone, 601 Electroconvulsive shock, 241 Histamine, 321, 421 Mice, 17, 133, 141, 259, 369, 457, 481, Electromyography, 351 Histamine H, receptor, 321 587, 661 Emotionality, 277 (’H]Ketanserin binding, 309 Microdialysis, 153 Emulphor 620, 521, 527 Histogranin, 49 Microstructural analysis, 463 Estrogen, 55, 369 (HJMK-801 binding, 65 MK-801, 587 Estrous cycle, 369 Holeboard, 277 Monkeys, 641 Ethanol, 199, 521, 527 Host defense, 675 Monoamines, 457, 593 Etonitazene, 571 Hot plate test, 421 Morphine, 17, 299, 421 Evodiamine, 293 H, receptor, 421 Motivation, 369, 437, 641 Exercise, 635 HPLC, 533 Motor activity, 627 Exploration, 277 Humans, 171 Motor behavior, 313 Exploratory behavior, 375 Hunger, 369 Mouse, 453 Extinction, 437 Hyperactivity, 115 Muscarinic M, receptor agonists, 339 Hypercapnia, 499 Muscimol, 253 Fasting, 405 Hypertension, 225 Muscle dysfunction, 517 Fawn-Hooded rats, 265 Hypothalamus, 485 Muscle rigidity, 351 Feeding, 271, 287 Hypothermia, 587 Mydriasis, 219 Feeding behavior, 153 Hypoxia (asphyctic, hemic), 457 Myoclonus, 533 Female, 369, 661 Hypoxia, 533 Fencamfamine, 35 Naloxone, 313, 587 Fenfluramine, 41, 287 IL-16, 141 Naltrexone, 277 Fever, 293 Imipramine, 147 Naltrexone by minipump, 413 5-HT, 581 Immunotherapy, 399 NAT, 241 5-HT,, agonists, 375 In situ hybridization, 655 Neonatal exposure, 115 5-HT,, receptors, 593 In vivo binding, 211 Neonatal opioid blockade, 277 5-HT, receptors, 593 Inbred mice, 431 Neostriatum, 431 5-HT>,, 545 Inbred strains, 17 Neuron-specific enolase, 491 5-HT>, receptors, 309 Incremental repeated acquisition, 641 Neuropeptide Y, 473 5-HT>,, receptor binding sites, 383 Ingestion, 463 Nicotine, 191, 233 5-HT., 545 Inheritance, 661 Nitric oxide, 265, 369 5,7-Dichlorokynurenic acid, 305 Inhibitor of enkephalin degradation, 133 Nitric oxide (NO), 327 5,7-Dihydroxytryptamine, 649 Insulin, 55 Nitric oxide synthase, 265 Flavor-association, 121 Interactions between CCK and Nitrogen excretion, 405 Flinders Line rats, 505 enkephalins, 133 Nitrous oxide, 351 Flupenthixol, 127 Intracranial self-stimulation, 41 NMDA antagonists, 9 Food anticipation, 207 Ipsapirone, 375 N-Methyl-D-aspartate receptor, 65 Food deprivation, 245 Ischemia, 533 N-Methyl-D-aspartate, 49 Food intake, 309, 369, 473, 581 Isolation, 481 Nociceptive test, 421 Food reward, 121 Isoproterenol, 241 Noradrenaline, 481 Forced running, 551 NPA, 127 Frontal cortex, 627 Jump test, 421 NS-3 (CG3703), 499 Functional castration, 55 Nucleus accumbens, 437, 627 Functional model, 219 Kainate, 505 Ketanserin, 383 Obese Zucker rats, 309 GABA, 181 Kidney, 551 Olfactory bulb, 551 GABA,, 593 Olfactory sensation, 233 Galanin, 655 L-Arginine, 327 Ontogeny, 613 y-Glutamyltranspeptidase, 491 Larus, 607 Open field, 277 Gastric emptying, 581 L-BOAA, 445 Operant, 271 Gastrin-releasing peptide, 463 Lead, 97 Operant behavior, 437, 641 Genes, 619 Learned helplessness, 147 Opiate receptors, 313 Genetic strain, 191 Learning, 207, 641, 661 Opiates, 271, 351 Gepirone, 477 Lever press, 369 Opioid, 271, 445, 571 Ginseng total saponin (GTS), 23 Lick pattern, 121 Opioid plasticity, 277 Glutamate, 627 Lipopolysaccharide, 675 Opioid receptors, 35 Glutathione, 491, 635 Lithium, 299, 345 Optical isomers, 601 Glycine, 199, 305 L-N°-Monomethylarginine (L-MeArg), 327 Oral activity, 649 Goldfish, 77 Locomotion, 49, 277 Oral drug, 245 Grip strength, 517 Locomotor activity, 9, 133, 163, 333, 389, Oral route, 571 Growth hormone releasing factor, 305 521, 527 Oxytocin, 339 Gulls, 97, 607 Locus coeruleus, 481 Oxytocin receptor antagonists, 339 Loss of the righting reflex, 199 Habituation, 445 Pain sensitivity development, 313 Haloperidol, 77, 181, 259, 587 Male rats, 29 Palatability, 345 Hamsters, 375 Manganese, 607 Paraventricular hypothalamus, 287 Head shakes, 309 Mefenorex, 485 Parietal-cingulate cortex, 627 Head-twitch response, 545 Melatonin, 241 Passive avoidance, 321 Heart, 551 Membrane fluidity, 65 Passive avoidance learning, 65 Heart rate, 253 Memory, 641, 661 PDE inhibitors, 211 SUBJECT INDEX Peptide receptor antagonist, 463 Rolipram, 211 Tail pinch test, 421 Pergolide, 389 RS-86, 339 Tail withdrawal, 587 Phencyclidine, 49 RTI compounds, 163 Tar, 233 Phenylpropanolamine, 287 RU486, 405 Taste, 233, 345 Physostigmine, 505, 641 Taste aversion, 345 Picrotoxin, 253, 505 Saccharin, 345 Taste avoidance, 345 Pigeons, 107 Saccharin preference, 413 Taste reactivity, 345 Pilocarpine, 505 SCH-23390, 153, 259, 359 Temporal, 97 Pineal gland, 241 Schedule-induced polydipsia, 71, 245 Temporal response, 641 Piribidil, 41 Scopolamine, 1, 499 Teratogenic, 491 Place conditioning, 35 Secondary CTL response, 399 TGFa, 593 Place preference, 77 Seizures, 505 THC, 141 Plasma iron, 675 Self-administration, 563 Thermoregulation, 293 Plus-maze, 277, 413 Sensitivity, 107 Thioperamide, 321 Postnatal, 97, 607 Sensorimotor reactivity, 191 Threshold, 107 Poststroke SHRSP, 509 Sensory factors, 91 Thyroxin, 55 Postsynaptic action, 375 Sensory gating, 191 Time course, 539 Postsynaptic a,-adrenoceptors, 219 Serine, 199 Time perception, 641 Prazosin, 225 Serotonergic agonists, 671 TNFa, 141 Pregnancy, 313 Serotonin, 41, 287, 485, 533, 649, 671 TO mice, 9 Prenatal cocaine effects, 115 Sex differences, 563 Tobacco withdrawal, 91 Prenatal drug effects, 313 Sexual behavior, 29 Tolerance, 9, 259, 665 Preweanling rat, 127 Sexual difference, 613 Toxicology, 607 Progesterone, 369, 661 o Receptor, 587 Training procedures, 107 Progressive ratio, 641 6-Hydroxydopamine, 649 Transgenic mice, 593 Propranolol, 225 Skeletal muscle, 351 Triazolam, 171 Psychopharmacology, 299 SKF-38393, 359 Triiodothyronine, 55 Puffing, 233 Sleep time, 199 Tryptophan hydroxylase, 431 Smoking behavior, 91 Turning, 389 Quaking mutation, 333 SND 919, 29 Tween-80, 521, 527 Quinelorane, 389 Sodium nitroprusside (SNP), 327 Tween-20, 521, 527 Quinpirole, 153, 649 Spontaneously hypertensive rats, 389 Two-bottle choice, 563, 619 Stereotypy, 49 Rat, 1, 181, 191, 211, 299, 327, 477, 499, Stimulus control, 71 Vehicles, 521, 527 539, 551, 581, 671 Stimulus fading, 571 Ventrolateral PAG, 445 Rat fetus, 359 Strength, 517 Ventrolataral striatum, 153 Receptor, 545, 649 Stress, 225, 253, 551 Vestibular nucleus in vitro, 665 Reinforcement, 17, 35, 77, 271, 437, 619 Striatal dopamine turnover, 1 Vigabatrin, 181 Repeated testing, 277 Striatum, 383, 627 Visible burrow system, 655 Resting metabolic rate, 55 Strychnine, 199 Vulnerability, 563, 619 Retina, 83 Subordinate, 655 Reverse tolerance, 23, 259 Substance P, 77 Water consumption, 671 Reward, 563, 619 Sulpiride, 153 Wheel running, 405 Rhesus monkeys, 571 Superoxide dismutase, 635 WIN 35,428, 163, 627 Righting reflex, 665 Supersensitivity, 649 Rimcazole, 587 Yawning, 339, 389 Ritanserin, 383 Tail flick test, 421 YC8 lymphoma, 399 PHARMACOLOGY BIOCHEMISTRY & BEHAVIOR VOLUME 50 1995 AUTHOR INDEX Acri, J. B., 191 Darlington, C. L., 665 Grady, D. R., 271 Landauer, M. R., 521 Aguilar, C., 77 Darmani, N. A., 545 Grauffel, C., 181 Lau, C. E., 71, 245 Aizenstein, M. L., 35 Dauge, V., 133 Grunberg, N. E., 199 Le Maho, Y., 405 Akiyama, K., 613 DeCabo, C., 277 Lee, E. H. Y., 327 Alova, L., 457 DeLucia, R., 35 Hasenfratz, M., 241 Lee, T. F., 299 Anderson, L. A., 313 De Montis, M. G., 147 Heal, D. J., 219 Lemaire, S., 41 Andrews, J. S., 219 De Natale, G., | Henni, H., 83 LeSage, M., 527 Arnon, E., 55 De Ovellis, V., 453 Henningfield, J. E., 91 Levine, A. S., 277 Aulakh, C. S., 309 Desole, M. S., 1 Hilakivi-Clarke, L. A., 593 Leyva, J., 453 Avgustinivich, D. F., 333, 383 Deutsch, S., 593 Hiramoto, N. S., 399 Liebeskind, J. C., 587 Aziz, N., 533 DiGregorio, G. J., 207 Hiramoto, R. N., 399 Little, H. J., 9 D’Istria, M., 245 Hitri, A., 593 Lépez-Rubalcava, C., 375 Battig, K., 241 Dourish, C. T., 581 Hogan, J. B., 521 Lucion, A., 671 Bailey, D., 91 Drugan, R. C., 551 Holmes, P. V., 551, 655 Luczak, S., 551 Baldinger, B., 233 Drumheller, A., 83 Hough, I. B., 421 Banchard, D. C., 655 Dumont, M., 49 Hsiao, S., 121 Ma, F., 253 Barbieri, E. J., 207 Dyck, J. B., 351 Huang, A.-M., 327 Maeyama, K., 321 Barke, K. E., 421 Husband, A. J., 675 Maher, J. R., 627 Barron, S., 107 Elands, J., 181 Hutchinson, M. A., 665 Maione, S., 453 Bartke, A., 563, 619 Maj, M., 245 Enrico, P., 1 Baudrie, V., 309 Esposito, G., 1 Inoue, K., 153 Malan, A., 405 Benson, K. A., 521 Irvine, J., 107 Maldonado, H., 445 Exton, M. S., 675 Berrino, L., 453 Ito, H., 153 Martin, B. R., 601 Billington, C. J., 277 Maslova, G. B., 383 Blanchard, R. J., 655 Falk, J. L., 71, 253 Jaccoby, S., 55 Matsumoto, K., 481 Bodnar, R. J., 421 Farr, S. A., 369, 661 Jaffe, J. H., 171 Matsumoto, R. R., 533 Bolanos, C. A., 127 Ferko, A. P., 207 Jensen, R. A., 563, 619 Matsuoka, Y., 509 Bouali, S. M., 473 Ferland, J., 551 Jolicoeur, F. B., 83, 473 Mattioli, R., 77 Brady, L. S., 655 Fernandez-Guasti, A., 375 Jones, C. A., 572 Mazzola-Pomietto, P., 305 Briley, M., 485 Ferrari, F., 29 McCullough, L. D., 437 Brown, K. J., 191 Flood, J. F., 369, 661 Kaiser, F. E., 661 McDougall, S. A., 127 Brunette, J. R., 83 Fournier, A., 473 Kang, J.-G., 23 McDowell, K. P., 627 Brus, R., 649 Francis, J., 581 Katner, J. S., 259 McGlacken, G., 619 Frederick, D. L., 641 Buckett, W. R., 225 Kellar, K. J., 593 McMahon, L., 293 Bull, D. F., 675 Fresu, L., 1 Keshet, G. I., 413 Medici, C. N., 313 Burger, J., 607 Friedman, H., 141 Kest, B., 587 Meguro, K.-I., 321 Burger, M. J., 97 Fujikawa, M., 339 Kigoshi, S., 233 Meisch, R. A., 571 Butler, S. A., 225 Fujisaki, Y., 153 Kim, H.-S., 23 Meliska, C. J., 563, 619 Butschky, M. F., 91 Fujiwara, Y., 613 Kimura, K., 499 Merali, Z., 49 Furukawa, T., 339 King, M. G., 675 Miele, M., | Carney, J. M., 163 Kinoshita, K., 509 Migheli, R., 1 Castro, C. A., 521 Gambarana, C., 147 Kiriike, N., 153 Millan, M. H., 505 Challet, E., 405 Georgiev, V., 457 Klein, S., 171 Minamoto, Y., 211 Chang, N. J., 351 Gerdes, C. F., 545 Klein, T. W., 141 Mizuki, Y., 265 Chaouloff, F., 309 Getova, D., 457 Knoédgen, B., 181 Mosgil, J. S., 587 Chen, C. F., 299 Ghanta, V. K., 399 Koch, J. E., 421 Monteleone, P., 241 Cherel, Y., 405 Ghiglieri, O., 147 Kolpakov, V. G., 383 Moran, P., 181 Contreras, R., 491 Giardina, W. J., 517 Korpi, E. R., 593 Moret, C., 485 Cooper, S. J., 581 Gibbs, J., 463 Kostrzewa, R. M., 649 Morley, J. E., 369, 661 Corduban, T.-D., 593 Gibertini, M., 141 Kozlachkova, E. Y., 431 Moroz, I., 305 Corringer, P.-J., 133 Gillam, M. P., 641 Kudryavtseva, N. N., 431 Muehlenkamp, F., 671 Coupry, I., 309 Giuliani, D., 29 Kulikov, A. V., 383, 431 Miiller, W. E., 65 Coy, D. H., 463 Glennon, R. A., 601 Kunko, P. M., 627 Muramatsu, I., 233 Crawley, J. N., 655 Gobaille, S., 181 Kuroda, S., 613 Murphy, D. L., 309 Critchley, D., 581 Gochfeld, M., 97, 607 Kurth, P., 437 Godoy, A. M., 445 Kuzmin, A., 17 Nagashima, M., 339 Dal Cason, T. A., 601 Goldberg, R., 593 Nalwalk, J. W., 421 D’Alessandro, N., 147 Gomita, Y., 477 Lafond, G., 83 Nam, K.-Y., 23 Vil VIII AUTHOR INDEX Newton, C., 141 Rabbani, M., 9 Shibata, S., 207 Tsuchida, K., 613 Nicolaidis, S., 485 Ravi, R., 635 Shukla, V. K., 49 Nikulina, E. M., 333 Reyes, E., 491 Shultz, P. L., 115 Ujike, H., 613 Rezvani, A. H., 265 Siegel, S., 299 Ukai, Y., 499 Oda, Y., 233 Roache, J. D., 171 Skrinskaya, J. A., 333 Ushijima, I., 259 Ogasawara, T., 499 Robin, J.-P., 405 Smith, G. P., 121, 463 van den Buuse, M., 389 Oh, H., 551 Robinson, B., 491 Smith, P. F., 665 Vandergriff, J. L., 563 Oh, K.-W., 23 Robinson, S. E., 627 Smith, R. F., 313 Varlinskaya, E. I., 359 Oishi, R., 477 Robinson, S. R., 359 Smotherman, W. P., 359 Vasconcelos, L., 77 Ojima, K., 481 Robinzon, B., 55 Snapir, N., 55 Viveros, M. P., 287 Okuno, M., 153 Roques, B. P., 133 Sokolowski, J. D., 437 Vogel, W. H., 671 Olds, M. E., 41 Rossi, F., 453 Somani, S. M., 635 Ono, M., 211 Rudski, J. M., 271 Soong, S.-J., 399 Wang, L. C. H., 299 Opitz, M., 457 Rybak, I. P., 635 Spicer, M. S., 115 Watanabe, H., 481 Orosco, M., 485 Stancheva, S., 457 Watanabe, S., 211 Ort, S., 491 Saah, M. I., 191 Steardo, L., 245 Watanabe, T., 321 Overstreet, D. H., 505 Sakai, N., 321 Stephens, D. N., 219 Weigel, R., 65 Sakurai, E., 321 Sternberg, W. F., 587 Weinger, M. B., 351 Pallotta, M., 453 Salamone, J. D., 437 Stoll, S., 65 Weinstock, M., 413 Parker, L. A., 305, 345 Sampson, A., 171 St-Pierre, S., 473 Wellman, P. J., 287 Paschke, U., 65 Sarhan, S., 181 Stratford, T. R., 463 Williams, K. L., 199 Paule, M. G., 641 Sasaki, H., 321 Suarez, M. D., 369 Wismer, C. T., 517 Pechnick, R. N., 587 Schechter, M. D., 539 Sundby, S., 527 Wright, E. J.,9 Peek, A. E., 271 Scher, D. M., 551 Peoples, L. L., 115 Scheuer, K., 65 Tagliamonte, A., 147 Yamada, K., 339 Petrov, E. S., 359 Schneider, H. H., 211 Taira, T., 593 Yamada, M., 265 Pickworth, W. B., 91 Schulze, G. E., 641 Takita, M., 225 Yamagami, S., 153 Planeta, C. S., 35 Seiler, N., 181 Tamura, M., 499 Yamaguchi, M., 219 Plech, A., 649 Semenova, S., 17 Thomas, D., 277 Yamamura, M., 509 Poling, A., 527 Seong, Y.-H., 23 Tolliver, B. K., 163 Yamashita, S., 477 Popova, N. K., 333, 383, 431 Serino, I., 245 Tomie, A., 115 Yanai, K., 321 Prow, M. R., 225 Shehata, C. W., 521 Tow, S., 293 Young, R., 601 Pucilowski, O., 271, 505 Shekhar, A., 253 Truong, D. D., 533 Pujol, A., 287 Shepanek, N. A., 313 Tsai, T. H., 293 Zvartau, E., 17